Cymabay Stock Price (NASDAQ:CBAY)

Add to My Stocks
$12.25 $0.06 (0.49%) CBAY stock closing price Aug 17, 2018 (Closing)
Prev Close* : $12.19
Market Cap:
$723.4M
Day Low: $12.01
52 Week Low: $5.91
Open: $12.18
Volume: -
Day High: $12.35
52 Week High: $15.59
Dividend:
0.00

Latest Stock Market News

Latest Articles

Cymabay News - From Partners

CBAY Stockcharts

View CBAY PE ratio, PS ratio stocks charts and compare with peers.
CBAY Chart
Note: Compare Cymabay stock price history with the index and industry peers.

Cymabay Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Cymabay Returns

ROE
(return on equity)

Cymabay Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

CBAY Industry Peers

Company Price Change (%)
Ventrus Biosciences (ASMB)36.550.17 (0.46%)
Amphastar Pharma (AMPH)17.820.22 (1.22%)
Bristol-myers Squibb (BMY)60.890.22 (0.36%)
Pfizer (PFE)42.090.67 (1.62%)
Esperion Therapeutics (ESPR)48.121.45 (3.11%)
Aegerion Pharma (AEGR)1.970.1 (5.35%)
Novo Nordisk (NVO)47.460.31 (0.65%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Supernus Pharma (SUPN)44.81.3 (2.99%)
Corium (CORI)8.930.24 (2.76%)
Mallinckrodt (MNK)34.690.55 (1.61%)
Dr. Reddy's Laboratories (RDY)33.830.52 (1.56%)
BAUSCH HEALTH (BHC)21.890.2 (0.92%)
Mylan (MYL)38.150.3 (0.79%)
Allergan (AGN)185.61.39 (0.75%)
Top gainers from Medical-Generic Drugs industry
* As of Aug 18, 2018
CompanyPriceChange (%)
Adamas Pharma (ADMS)22.430.41 (1.8%)
Progenics Pharma (PGNX)7.810.08 (1.01%)
Akorn (AKRX)18.990.16 (0.84%)
Teligent (TLGT)4.260.01 (0.23%)
Top losers from Medical-Generic Drugs industry
* As of Aug 18, 2018

CymaBay Therapeutics Inc Stock News - Partner Headlines

Cymabay Financial Statements

income statement20172016201520142013
Net Sales or Revenues10M----
Net Income-27.55M-26.67M-15.52M-31.91M-10.07M
Total Operating Expense31.31M25.58M25.89M24M9.39M
View Cymabay income statement
balance sheet20172016201520142013
Total Assets104.24M19.35M43.07M37.47M32.5M
Total Liabilities19.3M15.42M14.96M23.62M13.9M
Shareholders Equity84.94M3.93M28.11M13.85M18.59M
View Cymabay balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-3.04M--1.6M-
Net Cash from (used by) Operating Activities-19.63M-23.35M-23.32M-21.11M-8.45M
Increase (Decrease) in Prop Plant And Equipment-0.02M-0.04M--0.1M-
View Cymabay cash flow statement

Cymabay Stock Message Board

As of last trading day, Cymabay stock price was $12.25. Cymabay market capitalization is $723.4M and it represents the total market value of CBAY stock. A value investor must look at the fundamentals of a stock, and perform Cymabay valuation, even though in the short-term, sentiment and current breaking news might affect Cymabay stock price.

Demand for a stock decides its stock market price. For example, if more investors want to buy CBAY stock than sell it, then Cymabay stock price goes up. Conversely, if more investors wanted to sell CBAY stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Cymabay stock quote data shows the number of shares traded. For Ex: 304,516 Cymabay shares were traded as of last trading day, as seen from Cymabay stock chart. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Cymabay does not pay dividends. Cymabay stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.